ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
US Tech 100
20,897.20
-1.35%
Dow Jones
42,992.21
-0.77%
Brent Oil
73.835
0.29%
Bitcoin
93,421.01
-0.11%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aclaris Therapeutics Inc (ACRS) Quote

Aclaris Therapeutics Inc

Aclaris Therapeutics Inc (ACRS)

NASDAQ
2.73
-0.185
(-6.35%)
Closed December 29 4:00PM
Delayed by 15 minutes
2.85
0.12
(4.40%)
After Hours: 7:42PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.85
Bid
2.73
Ask
3.05
Volume
539,571
2.71 Day's Range 2.96
0.8555 52 Week Range 5.17
Market Cap
203.578M
Previous Close
2.915
Open
2.96
Last Trade
12
@
2.8
Last Trade Time
Financial Volume
$ 1,500,442
VWAP
2.7808
Average Volume (3m)
2,584,407
Shares Outstanding
71,430,942
Dividend Yield
-
PE Ratio
-2.20
Earnings Per Share (EPS)
-1.24
Revenue
31.25M
Net Profit
-88.48M

About Aclaris Therapeutics Inc

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from... Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.aclaristx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Aclaris Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACRS. The last closing price for Aclaris Therapeutics was $2.92. Over the last year, Aclaris Therapeutics shares have traded in a share price range of $ 0.8555 to $ 5.17.

Aclaris Therapeutics currently has 71,430,942 shares outstanding. The market capitalization of Aclaris Therapeutics is $208.22 million. Aclaris Therapeutics has a price to earnings ratio (PE ratio) of -2.20.

Ask ADVFN Intelligence (AI)

ACRS Latest News

More News

Form S-3 - Registration statement under Securities Act of 1933

December 19 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 12 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 06 2024
Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities

December 04 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WAYNE, Pa., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS)(the “Company” or “Aclaris”), a clinical-stage biopharmaceutical company focused on developing novel drug...

December 03 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

December 03 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

November 27 2024
Edgar (US Regulatory)

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

WAYNE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for...

November 26 2024
GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities

November 25 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.114.014598540152.743.122.7110537992.84897623CS
4-1.01-26.16580310883.864.242.719745943.37911238CS
121.65137.51.25.171.1225844073.58109732CS
261.73154.4642857141.125.171.114906653.12668879CS
521.82176.6990291261.035.170.855513600902.24621214CS
156-12.47-81.396866840715.3218.95830.590211847484.74031697CS
2601.0154.89130434781.8430.3750.590210564027.58413596CS

ACRS - Frequently Asked Questions (FAQ)

What is the current Aclaris Therapeutics share price?
The current share price of Aclaris Therapeutics is $ 2.85
How many Aclaris Therapeutics shares are in issue?
Aclaris Therapeutics has 71,430,942 shares in issue
What is the market cap of Aclaris Therapeutics?
The market capitalisation of Aclaris Therapeutics is USD 208.22M
What is the 1 year trading range for Aclaris Therapeutics share price?
Aclaris Therapeutics has traded in the range of $ 0.8555 to $ 5.17 during the past year
What is the PE ratio of Aclaris Therapeutics?
The price to earnings ratio of Aclaris Therapeutics is -2.2
What is the cash to sales ratio of Aclaris Therapeutics?
The cash to sales ratio of Aclaris Therapeutics is 6.24
What is the reporting currency for Aclaris Therapeutics?
Aclaris Therapeutics reports financial results in USD
What is the latest annual turnover for Aclaris Therapeutics?
The latest annual turnover of Aclaris Therapeutics is USD 31.25M
What is the latest annual profit for Aclaris Therapeutics?
The latest annual profit of Aclaris Therapeutics is USD -88.48M
What is the registered address of Aclaris Therapeutics?
The registered address for Aclaris Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Aclaris Therapeutics website address?
The website address for Aclaris Therapeutics is www.aclaristx.com
Which industry sector does Aclaris Therapeutics operate in?
Aclaris Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INTZIntrusion Inc
$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
$ 0.967551
(185.83%)
398.95M
LITMSnow Lake Resources Ltd
$ 1.61
(82.95%)
131.98M
NEUPNeuphoria Therapeutics Inc
$ 4.11
(-92.30%)
936.47k
VIRXViracta Therapeutics Inc
$ 0.16
(-32.49%)
9.31M
PRFXPainReform Ltd
$ 3.48
(-28.98%)
926.19k
AIREreAlpha Tech Corporation
$ 2.56
(-28.49%)
8.26M
AVGRAvinger Inc
$ 0.9721
(-24.05%)
2.11M
AILEiLearningEngines Inc
$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
$ 0.967551
(185.83%)
398.95M
RGTIRigetti Computing Inc
$ 17.08
(10.62%)
305.79M
XTIAXTI Aerospace Inc
$ 0.03935
(-1.63%)
268M
QSIQuantum Si Inc
$ 3.585
(66.74%)
256.01M

ACRS Discussion

View Posts
glenn1919 glenn1919 4 weeks ago
ACRS.........................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 month ago
ACRS.......................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
retireat40 retireat40 1 month ago
May see $6 this week. 
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
THATS TOP
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
READY TO BREAK 5.00
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
ACRS BIO BEAST BREAKING NEW HIGHS
👍️0
wesley_ wesley_ 1 month ago
$4+ weee
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
ACRS MONSTER BIO
👍️0
wesley_ wesley_ 1 month ago
$3+
👍️0
glenn1919 glenn1919 1 month ago
ACRS...........https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 months ago
ACRS................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
wesley_ wesley_ 2 months ago
$2.23 love it
👍️0
glenn1919 glenn1919 2 months ago
ACRS..............................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 months ago
ACRS.........................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 months ago
ACRS.............................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
wesley_ wesley_ 2 months ago
nice set up
👍️0
glenn1919 glenn1919 5 months ago
ACRS.............https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 5 months ago
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
👍️0
Monksdream Monksdream 9 months ago
ACRS under $2
👍️0
glenn1919 glenn1919 10 months ago
ACRS..........................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
Triple nickle Triple nickle 12 months ago
No worries here still adding.
👍️0
TheFinalCD TheFinalCD 1 year ago
ACRS The agreement includes an upfront payment of $15 million, regulatory and commercial milestones, and royalties
👍️0
81vette 81vette 1 year ago
7.4M short,1.5M available to short,fee 1%,rebate is 4.5% holy crap they pay you to short it,no wonder it’s shorted so much and beaten down,squeeze could be huge
👍️0
81vette 81vette 1 year ago
Could be interesting,beaten down,definitely run room
👍️0
TheFinalCD TheFinalCD 1 year ago
ACRS NEWS https://www.globenewswire.com/news-release/2023/12/05/2791335/37216/en/Aclaris-Therapeutics-Announces-Patent-License-Agreement-with-Sun-Pharma-for-Alopecia.html

https://finviz.com/quote.ashx?t=ACRS&p=d

https://dilutiontracker.com/app/search/ACRS


https://finance.yahoo.com/news/aclaris-acrs-loses-83-17-143502790.html
👍️0
Terpi Terpi 1 year ago
Shake and Bake
👍️0
Zorro Zorro 1 year ago
Way overdone. Shorter's paradise. Lol!
👍️0
Penny chatter Penny chatter 1 year ago
Thanks Clay
👍️0
Afterhoursearnings3 Afterhoursearnings3 1 year ago
Grabbed some here on the overreaction
👍️0
TimeFades TimeFades 1 year ago
In
👍️0
TheFinalCD TheFinalCD 1 year ago
ACRS.67 Aclaris Therapeutics to stop development of rheumatoid arthritis drug

https://finviz.com/quote.ashx?t=ACRS&ty=c&ta=1&p=d

https://dilutiontracker.com/app/search/ACRS?a=dbb88c
👍️0
alchemytrader alchemytrader 4 years ago
I was short premarket 20.30 then quickly covered 20.27 for scratch because she was still holding up.

Shes a scary on to short. ran to 24.00 at open before fading.

In hindsight, should have shorted 24.00 but was busy with other plays.
👍️0
SteevoTrader SteevoTrader 4 years ago
ACRS offering more than 5m shares at $17.50/per share
👍️0
alchemytrader alchemytrader 4 years ago
The way she kept grinding back to 19s could gap.

Who knows in this market. Robin Hood traders buy anything.
👍️0
SteevoTrader SteevoTrader 4 years ago
Are we seeing a dump tomorrow?
👍️0
alchemytrader alchemytrader 4 years ago
Oh really? hit 19.95 today...
👍️0
ClayTrader ClayTrader 4 years ago
* * $ACRS Video Chart 01-19-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Marketwise Marketwise 4 years ago
One month later. Take a look now. E-trade certainly did you no favor.
👍️0
Docstemcell2020 Docstemcell2020 4 years ago
Nice!
👍️0
Serge521 Serge521 4 years ago
Im so happy Etrade wouldnt let me buy this couple of days ago..
I owe Etrade big
👍️0
interloper interloper 4 years ago
So ACRS trials will take 2 years but let’s rush a vaccine out by January 2021.
👍️0
DanSanTrades DanSanTrades 4 years ago
ACRS Trials gets an update from the FDA. Their now recruiting for the trial. Status updated over the weekend.

Clinical Trial Link
👍️0
ClayTrader ClayTrader 4 years ago
* * $ACRS Video Chart 07-20-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 years ago
* * $ACRS Video Chart 06-17-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 years ago
* * $ACRS Video Chart 01-10-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
beambe beambe 5 years ago
good Volume
👍️0
XenaLives XenaLives 5 years ago
Just a shout out here, anyone with fundamental DD on ACRS?

👍️0
jonny_red jonny_red 5 years ago
3 Penny Stocks To Watch As Biotech Hits New Highs

$ACRS $ISEE $ONCY

https://www.transparenttraders.me/2019/10/3-penny-stocks-to-watch-as-biotech-hits.html

👍️0
ClayTrader ClayTrader 5 years ago
* * $ACRS Video Chart 10-29-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
BottomBounce BottomBounce 5 years ago
$ACRS Overbought Aclaris Therapeutics (ACRS) May Report Negative Earnings
👍️0

Your Recent History

NASDAQ
ACRS
Aclaris Therapeutics
TSX
IVQ.U
Invesque
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads